The aortic stents grafts market size is anticipated to be worth US$ 2.5 billion in 2023. The market is assumed to surge at a CAGR of 5% during the forecast period and, reach US$ 4.2 billion by 2033.
Key Market Trends and Highlights
| Attributes | Key Insights |
|---|---|
| Aortic Stents Grafts Market Size in 2023 | US$ 2.5 billion |
| Projected Market Value in 2033 | US$ 4.2 billion |
| Value-based CAGR from 2023 to 2033 | 5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for aortic stents grafts rose at a 4% CAGR between 2018 and 2022. The global market for aortic stents grafts is anticipated to expand at a moderate CAGR of 5% from 2023 to 2033.
| Report Attributes | Details |
|---|---|
| Market Value in 2018 | US$ 2.06 billion |
| Market Value in 2022 | US$ 2.5 billion |
| CAGR from 2018 to 2022 | 4% |
A rising incidence of aneurysm, expanding elderly population, poor lifestyle, and rising adoption of endovascular repair are boosting the aortic stents grafts industry, as reported by FMI analysts.
Endovascular repair has evolved as a routine treatment for those experiencing abdominal aortic aneurysms, and a substitute for patients who do not meet the criteria for open surgery.
Mounting aortic aneurysm (AA) cases around the globe is propelling the global aortic stents grafts sector. An estimated 167,249 deaths owing to aortic aneurysm (AA) were reported in 2017 globally, based on a paper released by the National Library of Medicine (LHM).
The rising popularity of testing techniques for early detection of aneurysms, combined with a growing elderly male population, is fueling the aortic stents grafts market. As aneurysm problems including AAA are asymptomatic, early detection might avert rupture and allow professionals to begin the right treatment approach.
The rising incidences of clinical trials and ongoing innovation in stents graft designs for improved endovascular aneurysm repair are expected to stimulate the aortic stents grafts market.
Principal Consultant
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and Germany. These two countries are expected to lead the market through 2033, with market values of US$ 730 million and US$ 600 million.
Expected Market Values in 2033
| The United States | US$ 730 million |
|---|---|
| China | US$ 512 million |
| The United Kingdom | US$ 510 million |
| Japan | US$ 220 million |
| Germany | US$ 600 million |
Forecast CAGRs from 2023 to 2033
| The United States | 5.3% |
|---|---|
| China | 5% |
| The United Kingdom | 4.9% |
| Japan | 4.5% |
| Germany | 5.1% |
The United States is expected to reach US$ 730 million by 2033, rising at a CAGR of 5.3%. A few factors that contribute to the development of the country are
Based on the Centers for Disease Control and Prevention (CDC), around 9,904 people died in the United States in 2019 as an outcome of an aortic aneurysm or aortic dissection. A smoking history was found in around 75 percent of the total abdominal aortic aneurysms.
Several government and commercial organizations are lobbying for better screening in the face of increased mortality rates from abdominal aortic aneurysms. For example,
Aortic stents graft trends in the United Kingdom are taking a turn for the better. A 4.9% CAGR is forecasted for the country from 2023 to 2033. By the end of this forecast period, the aortic stents grafts market in the United Kingdom is likely to total US$ 510 million.
The growing male senior population, and an increasing patient population affected by aortic aneurysms along with other cardiac disorders. According to the British Society of Interventional Radiology (BSIR), around 4% (nearly 80000) of men from 65 to 74 in England develop an abdominal aortic aneurysm (AAA). Around 6000 people die from AAA each year in England and Wales.
A substantial number of endovascular treatment procedures are conducted in the United Kingdom each year to address the aneurysm burden. This has resulted in a surge in market demand for aortic stents transplant items.
The aortic stents grafts market in China is expected to reach a value of US$ 512 million. The market in China is poised to expand at a CAGR of 5% through 2033.
The country's market is primarily driven by a fast-rising population size, an increase in the occurrence of aortic aneurysms, and a growing desire for less invasive operations.
China is becoming a desirable location for medical tourists with aneurysms owing to its expanding medical system and rapid development of novel medical gadgets at lower costs. Endovascular aneurysm repair (EVAR) operations are quite inexpensive in China. Aortic stents graft sales are increasing significantly.
Prominent medical equipment makers in China are attempting to expand their revenues by entering lucrative areas. This is expected to propel the development of the aortic stents grafts market throughout the forecast period. According to our analysts, Asia Pacific Excluding Japan (APEJ) had an industry share of 12% in 2022, with China dominating the way.
Expected to reach US$ 220 million by 2033, the aortic stents grafts market in Japan is set to experience positive growth. The country is likely to register a 4.5% CAGR from 2023 to 2033.
Japan has one of the world's most rapidly aging populations. This demographic trend has contributed to a high incidence of aortic diseases, such as abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs). As individuals age, they become more susceptible to these conditions, creating a substantial patient pool for aortic stents graft procedures.
The preference for minimally invasive medical procedures has been on the rise in Japan. Aortic stents grafts offer a less invasive alternative to traditional open surgeries for aortic aneurysm repair. Patients and healthcare providers favor these procedures due to short recovery times and reduced post-operative complications.
Japan is renowned for its advanced medical technology and innovation. This extends to the field of aortic stents grafts, with ongoing developments in stents graft designs, materials, and customization options.
Patient-specific solutions, often created using cutting-edge technologies like 3D printing, are becoming more common, improving treatment outcomes.
The aortic stents graft market in Germany is characterized by a strong healthcare system that upholds rigorous standards and embraces cutting-edge medical technology. With an aging population, there is an increasing demand for aortic stents grafts, as advanced age is a significant risk factor for aortic diseases.
Minimally invasive endovascular procedures are preferred in Germany, with aortic stents grafts providing a less invasive alternative to traditional open surgeries. This approach leads to short patient recovery times and reduced post-operative complications.
Germany is a leader in technological innovation within the healthcare sector, continually enhancing stents graft designs, materials, and customization options. These innovations contribute to the improved safety and effectiveness of aortic stents graft procedures.
The aortic stents grafts market in Germany is anticipated to rise at a 5.1% CAGR from 2023 to 2033. By the end of the said forecast period, a valuation of US$ 600 million is expected.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below table highlights how abdominal aortic stents graft is projected to lead the market in terms of materials, developing at 5.1% CAGR through 2033.
The hospitals segment is likely to spearhead sales based on source and is anticipated to witness a CAGR of 5.2% through 2033.
| Category | CAGR from 2023 to 2033 |
|---|---|
| Abdominal Aortic Stents Graft | 5.1% |
| Hospitals | 5.2% |
The abdominal aortic stents graft segment is expected to rise at a CAGR of 5.1% from 2023 to 2033.
According to the market analysis, the abdominal aortic stents graft segment is predicted to rule the aortic stents grafts industry with a whopping 92% share by 2023. Expanding aortic stents graft sales are related to a larger patient pool with abdominal aortic aneurysms and high blood pressure, a bad lifestyle, and habitual smoking.
The most widespread sort of aneurysm in males aged over 65 is abdominal aortic aneurysm (AAA). It happens in the aorta that goes through the abdomen. Delayed or negligent treatment might have catastrophic repercussions, including death. Every year, an enormous number of endovascular repair operations are conducted.
In terms of end users, hospitals are projected to lead the aortic stents grafts market, generating the lion's share of profit over the projected time frame. A CAGR of 5.2% is projected from 2023 to 2033.
Certain factors boosting demand for aortic stents graft systems include an increase in the sheer number of hospitals globally and increased government expenditures in building superior medical care. Due to a dearth of reimbursement rules and limited disposable cash in underdeveloped countries, people tend to seek treatment in hospitals.
Leading competitors in the aortic stents grafts market are heavily spending on studies and development. Aside from that, they are dominating the industry through various growth tactics including alliances, purchases, partnerships, and innovative product releases and authorizations.
| Attributes | Details |
|---|---|
| Estimated Market Size in 2023 | US$ 2.5 billion |
| Projected Market Valuation in 2033 | US$ 4.2 billion |
| Value-based CAGR 2023 to 2033 | 5% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value in US$ billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The aortic stents grafts market is expected to reach US$ 2.5 billion in 2023.
The market for aortic stents grafts is set to expand by a CAGR of 5% by 2033.
The aortic stents grafts industry is expected to reach US$ 4.2 billion by 2033.
China is likely to be the top-performing market, accounting for US$ 512 million in 2033.
The hospital segment is expected to rise at a 5.2% CAGR through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Abdominal
5.3.2. Thoracic
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers/Outpatient Surgical Centers
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. The USA
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product Type
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product Type
15.5.2.2. By End User
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product Type
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product Type
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product Type
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product Type
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product Type
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product Type
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product Type
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product Type
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product Type
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product Type
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product Type
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product Type
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product Type
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product Type
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Product Type
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Product Type
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Product Type
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Cook Medical, Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. W.L. Gore & Associates
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. MicroPort Scientific Corporation Inc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Medtronic Plc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Lombard Medical, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Endologix, INC.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Terumo Corporation Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Cardinal Health Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Becton, Dickinson and Company
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Cryolife Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Aortic Stents Grafts Market
